Trials / Withdrawn
WithdrawnNCT02980198
Study of IFN-K in Dermatomyositis
A Phase IIa, Single Blind, Randomized, Study to Evaluate the Safety, the Immunogenicity, and the Clinical and Biological Efficacy of IFNα-Kinoid (IFN-K) in Adult Subjects With Dermatomyositis
- Status
- Withdrawn
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Neovacs · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study is a Proof of Concept study aiming to evaluate the production of anti-IFNα antibodies (immune response) in adult subjects with dermatomyositis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | IFN-Kinoid | IM administration |
| OTHER | Placebo | IM administration |
| OTHER | ISA 51 | adjuvant |
Timeline
- Start date
- 2017-05-03
- Primary completion
- 2019-12-11
- Completion
- 2019-12-11
- First posted
- 2016-12-02
- Last updated
- 2020-01-03
Locations
8 sites across 4 countries: France, Germany, Italy, Switzerland
Source: ClinicalTrials.gov record NCT02980198. Inclusion in this directory is not an endorsement.